Kura Oncology Announces Three Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsGlobeNewsWire • 10/04/23
Kura Oncology Reports Preclinical Data Showing Ability of KO-2806 to Enhance Antitumor Activity of KRASᴳ¹²ᶜ Inhibitors in Non-Small Cell Lung CancerGlobeNewsWire • 09/28/23
Kura Oncology (KURA) Loses -22.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 07/11/23
Kura Oncology Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded WarrantsGlobeNewsWire • 06/14/23
Kura Oncology Announces Commencement of Public Offering of Common Stock and Pre-Funded WarrantsGlobeNewsWire • 06/13/23
Kura Oncology Presents Late-Breaking Clinical Data for Menin Inhibitor Ziftomenib at 2023 European Hematology Association (EHA) CongressGlobeNewsWire • 06/11/23
Kura Oncology Announces Late-Breaking Abstract Accepted for Oral Presentation at the 2023 European Hematology Association (EHA) CongressGlobeNewsWire • 05/30/23